We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Effect of aminoguanidine and copper(II) ions on the formation of advanced glycosylation end products. In vitro study on human serum albumin.
Nonenzymatic glycosylation of proteins is a weighty consequence of hyperglycaemia in diabetes. This study examines the possible effect of copper(II) ions on the glycosylation of human serum albumin (HSA) and the resulting formation of advanced glycosylation end products (AGEs). HSA in phosphate-buffered saline was incubated with 100 mmol/l glucose. The effect of addition of copper(II) ions and/or aminoguanidine bicarbonate (CAS 2582-30-1) was investigated. The determination of AGE levels derived from glycosylated/glycoxidated HSA was performed using a specific spectrofluorometric assay (excitation 346 nm; emission 418 nm). The results showed that the addition of copper(II) ions to the incubation medium containing glucose increased the formation of AGEs. Further, in the presence of copper(II) ions, a significant blockade of aminoguanidine inhibitory effect on the formation of AGEs was observed.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app